DB Pharm

DB Pharm is a South Korean pharmaceutical company established in 2006 that specializes in the development, manufacturing, and distribution of high-quality therapeutic agents. The company focuses on several key therapeutic areas, including respiratory, central nervous system (CNS), circulatory, and digestive health. DB Pharm is particularly active in the development of Incrementally Modified Drugs (IMDs) and combination therapies designed to improve patient compliance and efficacy. With its own research institute and manufacturing facilities, the company supplies a wide range of prescription and over-the-counter medicines to the domestic Korean market and is expanding its reach through strategic R&D initiatives.